Major Depressive Disorder: New Insight-Focused Report Forecasts a Landscape Shifting 2019-2029
22 janv. 2024 12h18 HE
|
Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Major Depressive Disorder - Eight-Market Drug Forecast and Market Analysis - Update" report has been added to ResearchAndMarkets.com's offering. A...
Global Major Depressive Disorder (MDD) Drug Market Report 2021: Therapeutics Market Will Grow to $7.9B by 2029
19 avr. 2021 07h58 HE
|
Research and Markets
Dublin, April 19, 2021 (GLOBE NEWSWIRE) -- The "Major Depressive Disorder - Global Drug Forecast and Market Analysis to 2029" report has been added to ResearchAndMarkets.com's offering. The MDD...
Cutting Edge Information Analyzes the Bristol-Myers Squibb / Otsuka Pharma Profit-Sharing Strategy for 2010 and Beyond
16 avr. 2009 10h17 HE
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - April 16, 2009) - The recently announced deal
between Bristol-Myers Squibb and Otsuka over Abilify will go a long way
toward shoring up both companies'...